EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced successful early clinical use of the ...

Ischemic stroke patients who were treated with the surgical removal of a clot fared better than patients who were treated with medications such as intravenous thrombolytics alone, according to a new ...

Prior to the introduction of intravenous heparin, surgical thrombectomy was the only effective means for treating a symptomatic lower extremity DVT, [21] but the reported outcomes of open surgical ...

With the addition of the Pounce™ XL Thrombectomy System, indicated for use in 5.5–10 mm peripheral arteries, the fully mechanical Pounce™ Thrombectomy Platform can now remove thrombi or emboli ...

Endovascular thrombectomy is a surgical procedure involving the removal of a clot from a blood vessel. Surgeons use a catheter device, and is intended to restore the normal blood flow. Embolism is a ...

With the addition of the Pounce™ XL Thrombectomy System, indicated for use in 5.5–10 mm peripheral arteries, the Pounce™ Thrombectomy Platform can now rapidly remove acute or chronic clot throughout ...

NEW ORLEANS — Compared with other treatment options and historical data, large-bore mechanical thrombectomy conferred reduced risk for in-hospital adverse clinical outcomes in high-risk patients with ...

Researchers report that the current standard of care for stroke should factor in procedure time when considering surgical intervention. By studying the number of attempts and the time spent performing ...

A metric for acute stroke care failed to identify preventable events in those patients requiring endovascular thrombectomy while also misidentifying quality of care in hospitals with a high volume of ...

In the United States, open surgical thrombectomy was largely abandoned in the 1980s owing to the severity of complications associated with its use. [30] The one area where its use remains is in those ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the ...